CD8A and melanoma: After studies showing prolonged survival and decreased MDSC function in tadalafil treated melanoma bearing mice, a human study in advanced melanoma shows no/marginal survival prolongation with 10 mg/day tadalafil but did see slight decreases in monocytic MDSC and slight increase in intratumoral CD4 and CD8 T cells [141].